Pioneering Tremor Care

Tremipen helps doctors measure and manage uncontrollable shaking of the hands

Tremor is the most common movement disorder worldwide and affects more than 1 billion people. Tremitas aims to help with the treatment of tremor-related diseases such as Parkinsons by enabling doctors to quantify the amount of tremor in a patient’s hands and to monitor development during treatment.

Tremitas has developed a handheld device called a Tremipen that can measure the amount of tremor in a patient’s hands. This allows doctors to not only quantify tremor, but also to monitor it during treatment. There is also a new version that can be used at home so that the patient can check what influences the symptoms. It comes along with an e-diary app and access to an online tremor community.

Tremitas is aiming for their Tremipen to become the global standard for doctors to measure tremor.

More Information

Get in touch via #GIS2021 B2B meeting


National Contact:
Tibor Zajki-Zechmeister
Tremitas GmbH
Klagenfurt, Austria

International Contact: